Related Experiment Videos
Cell density, negative proliferation control, and phosphorylation of retinoblastoma protein
1Melbourne Tumor Biology Branch, Ludwig Institute for Cancer Research, Australia.
Abstract:
Cell density negative control (CDNC) of normal human fibroblast proliferation occurs after stimulation by mitogens with different signal transduction mechanism. Delayed exposure to agents that interfere with CDNC, such as double-stranded RNA and vanadate, reveals the existence of a biochemical event, involved in CDNC, that occurs 5-8 hr after the beginning of mitogenic stimulation. This is earlier than the point of "mitogenic commitment," defined by the duration of mitogen exposure required for cell cycle entry (8-18 hr). Phosphorylation of the retinoblastoma gene product (pRB) begins 8-10 hr after mitogen stimulation and is nearly complete at 18 hr, just as the first cells enter S-phase. CDNC prevents pRB phosphorylation. Interferon beta delays pRB phosphorylation by up to 20 hr but has little effect on the timing of mitogenic commitment. Thus mitogenic commitment is located in time between CDNC and pRB phosphorylation. When agents that cause a release from CDNC are applied to dense, negatively controlled cultures after 18 hr of EGF stimulation, pRB phosphorylation occurs 6-8 hr after release. This suggests that the negatively controlled cells process the mitogenic signal but accumulate at a restriction point. The relatively early timing of CDNC-related events in the prereplicative phase raises the possibility that pRB phosphorylation is a consequence rather than a prerequisite for release from cell density negative control.
Insights
Cell density negative control (CDNC) in fibroblasts involves early biochemical events preceding mitogenic commitment. These events, occurring before retinoblastoma protein (pRB) phosphorylation, suggest pRB phosphorylation may follow, not precede, release from CDNC.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- Cell proliferation is regulated by various mechanisms, including cell density negative control (CDNC).
- Understanding the timing of CDNC events relative to cell cycle progression is crucial for comprehending growth regulation.
Purpose of the Study:
- To investigate the temporal relationship between CDNC and key cell cycle regulatory events, specifically mitogenic commitment and retinoblastoma protein (pRB) phosphorylation.
- To determine if pRB phosphorylation is a prerequisite for or a consequence of release from CDNC.
Main Methods:
- Normal human fibroblasts were stimulated with mitogens.
- Agents interfering with CDNC (double-stranded RNA, vanadate) were used to probe CDNC timing.
- Timing of mitogenic commitment, pRB phosphorylation, and cell cycle entry (S-phase) was assessed.
- Interferon beta was used to modulate pRB phosphorylation timing.
Main Results:
- CDNC involves biochemical events occurring 5-8 hours post-stimulation, preceding mitogenic commitment (8-18 hours).
- pRB phosphorylation begins 8-10 hours post-stimulation and is inhibited by CDNC.
- Interferon beta delays pRB phosphorylation but not mitogenic commitment.
- Release from CDNC after 18 hours of stimulation leads to pRB phosphorylation 6-8 hours later, suggesting cells arrest at a restriction point.
Conclusions:
- Mitogenic commitment occurs temporally between CDNC-related events and pRB phosphorylation.
- pRB phosphorylation appears to be a consequence, not a prerequisite, for release from cell density negative control.
- These findings suggest a novel regulatory role for CDNC in prereplicative phase events.